Sort
27,075 grants matching “cholesterol”
Non-coding RNA regulation of cholesterol homeostasis and atherosclerosis
$1,017,000Kathryn J Moore · New York University School Of Medicine · R35 · FY2021 · HL
Non-coding RNA regulation of cholesterol homeostasis and atherosclerosis
$1,017,000Kathryn J Moore · New York University School Of Medicine · R35 · FY2022 · HL
Development and assessment of methods for studying membrane protein structure and function
$1,016,791Lucy Forrest · National Institute Of Neurological Disorders And Stroke · ZIA · FY2025 · NS
Inflammatory Mechanisms and Treatment Strategies for Atherosclerosis in HIV
$1,016,685Steven Kyle Grinspoon · Massachusetts General Hospital · R01 · FY2012 · HL
Identifying new strategies for prevention of cardiovascular complications of diabetes
$1,016,402Karin E. Bornfeldt · University Of Washington · R35 · FY2022 · HL
Mechanisms and Optimal Combinations of Cisplatin Chemotherapy for Head and Neck Squamous Cell Carcinoma
$1,015,160Nicole Schmitt · National Institute On Deafness And Other Communication Disorders · ZIA · FY2018 · DC
Pathogenesis of Tick-Borne Flavivirus Infections
$1,013,392Marshall Bloom · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
NIDDM PRIMARY PREVENTION TRIAL (DPT-2)
$1,013,216Washington University · U01 · FY2001 · DK
Non-coding RNA regulation of cholesterol homeostasis and atherosclerosis
$1,012,830Kathryn J Moore · New York University School Of Medicine · R35 · FY2020 · HL
Cellular Biology Of Host/parasite Interactions
$1,012,704Ted Hackstadt · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
$1,012,470Suresh Ambudkar · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
THE ANTIHYPERTENSIVE AND LIPID-LOWERING TO PREVENT HEART ATTACK TRIAL RENEWAL
$1,012,341Barry Davis · University Of Texas Hlth Sci Ctr Houston · N01 · FY2015 · HL
STROKE INCIDENCE AND RISK FACTORS IN A TRI-ETHNIC REGION
$1,011,583Columbia University Health Sciences · R01 · FY2001 · NS
Determining the Fate of Transmembrane Proteins
$1,011,521Allan M Weissman · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
A novel siRNA therapeutic to prevent scarring and bleb failure after trabeculectomy
$1,009,285Tere M. Williams · Dub Therapeutics Inc. · R44 · FY2025 · EY
Cardiovascular disease, metabolic syndrome, microbes and metabolites in FHS
$1,008,629Ramnik J Xavier · Broad Institute, Inc. · R01 · FY2025 · HL
Physiology, Psychology, and Genetics of Obesity
$1,007,535Jack A. Yanovski · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2009 · HD
GENERAL ANESTHETIC SITES ON LIGAND GATED ION CHANNELS
$1,006,281Massachusetts General Hospital · P01 · FY2000 · GM
Behavioral Intervention Development Core
$1,004,863Julie Christine Lauffenburger · Brigham And Women'S Hospital · P30 · FY2024 · AG
Novel Cannabinoid Receptor Modulators
$1,004,709Malliga Iyer · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2021 · AA
Inborn Errors of Cholesterol Synthesis
$1,004,236Forbes Porter · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2013 · HD
Cell Cholesterol Efflux and HDL Formation
$1,003,951University Of California San Francisco · P01 · FY2002 · HL
Molecular And Immunopathology Of Experimental And Clinical Ocular Diseases
$1,003,255Chi-Chao Chan · National Eye Institute · ZIA · FY2012 · EY
Identifying new strategies for prevention of cardiovascular complications of diabetes
$1,002,374Karin E. Bornfeldt · University Of Washington · R35 · FY2024 · HL
Pathogenic Effects of Human Retroviruses on Hematopoietic and Adherent Cells.
$1,002,199Francis W. Ruscetti · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA